AI
Bengaluru-based Venomics AI has raised $2.7 million in a pre-seed funding round co-led by Speciale Invest and South Park Commons, with participation from Operators Studio.
The IISc spinout uses artificial intelligence, venom biology and laboratory screening to identify animal venom molecules with potential medicinal applications.
The funding will support the expansion of its Venom Atlas, strengthen AI-led drug discovery and laboratory screening capabilities, and help build its team.
Why It Matters
The funding highlights growing investor interest in AI-powered drug discovery and the potential of venom-derived molecules for developing new medicines.
CXO TechBOT Perspective
Venomics AI reflects the convergence of AI and biotechnology, opening new opportunities for innovative drug discovery and India's deep-tech ecosystem.
